AU2003298171A1 - Protein complexes associated with app-processing - Google Patents
Protein complexes associated with app-processingInfo
- Publication number
- AU2003298171A1 AU2003298171A1 AU2003298171A AU2003298171A AU2003298171A1 AU 2003298171 A1 AU2003298171 A1 AU 2003298171A1 AU 2003298171 A AU2003298171 A AU 2003298171A AU 2003298171 A AU2003298171 A AU 2003298171A AU 2003298171 A1 AU2003298171 A1 AU 2003298171A1
- Authority
- AU
- Australia
- Prior art keywords
- app
- processing
- protein complexes
- complexes associated
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03019642 | 2003-09-05 | ||
EP03019642.2 | 2003-09-05 | ||
PCT/EP2003/013980 WO2005023858A1 (en) | 2003-09-05 | 2003-12-10 | Protein complexes associated with app-processing |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003298171A1 true AU2003298171A1 (en) | 2005-03-29 |
Family
ID=34259147
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003298171A Abandoned AU2003298171A1 (en) | 2003-09-05 | 2003-12-10 | Protein complexes associated with app-processing |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003298171A1 (en) |
WO (1) | WO2005023858A1 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007028631A1 (en) * | 2005-09-09 | 2007-03-15 | H. Lundbeck A/S | Genetic risk factor for neurodevelopmental disorders and their complications |
WO2007096854A1 (en) * | 2006-02-21 | 2007-08-30 | The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin | Compositions and methods for modulating an immune response |
WO2008027017A1 (en) * | 2006-08-31 | 2008-03-06 | Singapore Health Services Pte Ltd | Modulation of neural activity and/or condition |
US20100169988A1 (en) * | 2006-12-06 | 2010-07-01 | Bernhard Kohli | Means and methods for isolating and determining novel targets for the treatment of neurodegenerative, neurological or neuropsychiatric disorders and compositions comprising the same |
AT504553B1 (en) * | 2006-12-06 | 2008-09-15 | Jsw Res Forschungslabor Gmbh | PEPTIDOMIMETICS MADE OF ROTATING AMINO ACIDS AND MEDICAMENTS CONTAINING THEREOF FOR THE TREATMENT OF NEURODEEGENERATIVE ILLNESSES |
EP2481408A3 (en) | 2007-03-01 | 2013-01-09 | Probiodrug AG | New use of glutaminyl cyclase inhibitors |
US9656991B2 (en) | 2007-04-18 | 2017-05-23 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
EP2321417B1 (en) * | 2008-08-20 | 2015-07-15 | Brainco Biopharma, S.L. | Stxbp1 as psychiatric biomarker in murine model system and its uses |
CA2772488C (en) | 2009-09-11 | 2018-04-17 | Probiodrug Ag | Heterocyclic derivatives as inhibitors of glutaminyl cyclase |
JP6026284B2 (en) | 2010-03-03 | 2016-11-16 | プロビオドルグ エージー | Inhibitors of glutaminyl cyclase |
JP5688745B2 (en) | 2010-03-10 | 2015-03-25 | プロビオドルグ エージー | Heterocyclic inhibitor of glutaminyl cyclase (QC, EC 2.3.2.5) |
WO2011131748A2 (en) | 2010-04-21 | 2011-10-27 | Probiodrug Ag | Novel inhibitors |
DK2686313T3 (en) | 2011-03-16 | 2016-05-02 | Probiodrug Ag | Benzimidazole derivatives as inhibitors of glutaminyl cyclase |
US9522170B2 (en) * | 2011-04-05 | 2016-12-20 | Alphabeta Ab | Methods of screening compounds for the fibril formation of Aβ peptides based on a decreased trimer/monomer ratio of a chaperone protein |
JP6359159B2 (en) * | 2017-07-25 | 2018-07-18 | 株式会社Mcbi | Biomarker for cognitive dysfunction disease and method for detecting cognitive dysfunction disease using the biomarker |
DK3461819T3 (en) | 2017-09-29 | 2020-08-10 | Probiodrug Ag | GLUTAMINYL CYCLASE INHIBITORS |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5837838A (en) * | 1997-03-14 | 1998-11-17 | The Burnham Institute | Bax inhibitor proteins |
US6383758B1 (en) * | 1998-01-09 | 2002-05-07 | The Governing Council Of The University Of Toronto | Alzheimer's related proteins and methods of use |
PT1105508E (en) * | 1998-08-17 | 2003-01-31 | Europ Lab Molekularbiolog | METHOD OF PURIFICATION OF BIOMOLECULES OR PROTEIN COMPLEXES |
GB0005895D0 (en) * | 2000-03-10 | 2000-05-03 | Glaxo Group Ltd | Novel assay |
US20020119155A1 (en) * | 2000-10-17 | 2002-08-29 | Myriad Genetics, Inc. | Protein-protein interactions in neurodegenerative diseases |
AU2003245987A1 (en) * | 2002-06-26 | 2004-02-02 | Cellzome Ag | Components of the presenilin-complex |
-
2003
- 2003-12-10 AU AU2003298171A patent/AU2003298171A1/en not_active Abandoned
- 2003-12-10 WO PCT/EP2003/013980 patent/WO2005023858A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2005023858A1 (en) | 2005-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003301680A1 (en) | Platinum complexes | |
AU2003300444A1 (en) | Recirculation port | |
AU2003282548A1 (en) | Nano-chem-fet based biosensors | |
AU2003213647A1 (en) | Multimeric binding complexes | |
AU2003272511A1 (en) | Cd44-binding ligands | |
AU2003298171A1 (en) | Protein complexes associated with app-processing | |
AU2003293769A1 (en) | Monocyclopentadienyl complexes | |
AU2003227861A1 (en) | Protein involved in cancer | |
AU2003260148A1 (en) | Aquarium | |
AU2003283562A1 (en) | Ligands | |
AU2003228525A1 (en) | Multimeric ligands with enhanced stability | |
AU2003202694A1 (en) | Torero protein | |
AU2003278718A1 (en) | Stars-a muscle-specification-binding protein | |
AU2003270055A1 (en) | Neurotransmission-associated proteins | |
AU2003285824A1 (en) | Potatoes with increased protein content | |
EP1504541B8 (en) | Rake-demodulator with multicode-finger | |
AU2003232176A1 (en) | Protein c variants with altered properties | |
AU2003300785A1 (en) | Carbohydrate-associated proteins | |
AU2003284432A1 (en) | Immunoreceptor proteins | |
AU2003254865A1 (en) | Akt2-BINDING PROTEIN | |
AU2003230727A1 (en) | Common ligand mimics: naphtoates | |
AU2003236908A1 (en) | Proteins | |
AU2003295760A1 (en) | Organelle-associated proteins | |
GB0305347D0 (en) | Protein with multiple interactions | |
AU2003245056A1 (en) | Treasury |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |